Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Clinical trial NCT04311957 · UNKNOWN
Trial details
- NCT number
- NCT04311957
- Sponsor
- Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-05-31
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.